Health technology reviews

" "

Vagal nerve stimulation

Status: Decision completed

View findings and decision

Policy context

Concerns about safety, efficacy and costs regarding whether Vagal Nerve Stimulation (VNS) provides adequate treatment for epilepsy and depression. VNS has been shown to affect blood flow to different parts of the brain, and affect neurotransmitters which are implicated in depression. Important clinical questions remain, especially around the efficacy of using of VNS to treat epilepsy and depression.

Primary criteria ranking

  • Safety = High
  • Efficacy = High
  • Cost = High

Assessment timeline

  • Draft Report Published: July 10, 2009
  • Public Comment Period: July 10 - 24, 2009
  • Final Report Published: July 31, 2009
  • HTCC Public Meeting: August 28, 2009